Revenue for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current revenue (TTM) is $3.22B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$3.22B
YoY change
+6.3%
5Y CAGR
+7.4%
Peak year (2025)
$3.07B
Cumulative revenue
$43.45B
Revenue history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Revenue history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $3.07B | +6.3% | ||
| 2024 | $2.89B | -2.0% | ||
| 2023 | $2.95B | +2.3% | ||
| 2022 | $2.89B | +1.9% | ||
| 2021 | $2.83B | +31.9% | ||
| 2020 | $2.15B | +16.4% | ||
| 2019 | $1.84B | +7.3% | ||
| 2018 | $1.72B | +7.4% | ||
| 2017 | $1.60B | +6.0% | ||
| 2016 | $1.51B | +7.9% | ||
| 2015 | $1.40B | -1.7% | ||
| 2014 | $1.42B | +3.9% | ||
| 2013 | $1.37B | +8.0% | ||
| 2012 | $1.27B | +6.2% | ||
| 2011 | $1.19B | +8.0% | ||
| 2010 | $1.10B | +4.6% | ||
| 2009 | $1.06B | +0.4% | ||
| 2008 | $1.05B | +3.0% | ||
| 2007 | $1.02B | +11.7% | ||
| 2006 | $913.30M | +30.5% | ||
| 2005 | $699.70M | +29.2% | ||
| 2004 | $541.60M | +10.4% | ||
| 2003 | $490.70M | +16.9% | ||
| 2002 | $419.70M | +5.7% | ||
| 2001 | $396.90M | -7.7% | ||
| 2000 | $430.10M | -8.3% | ||
| 1999 | $469.10M | +4.3% | ||
| 1998 | $449.70M | -0.6% | ||
| 1997 | $452.50M | -1.4% | ||
| 1996 | $458.80M | +11.1% | ||
| 1995 | $412.90M | +13.1% | ||
| 1994 | $365.10M | +4.7% | ||
| 1993 | $348.70M | +3.1% | ||
| 1992 | $338.20M | +2.6% | ||
| 1991 | $329.60M | +2.0% | ||
| 1990 | $323.20M | +4.7% | ||
| 1989 | $308.70M | +7.1% | ||
| 1988 | $288.20M | +13.8% | ||
| 1987 | $253.30M | +7.5% | ||
| 1986 | $235.60M | +23.9% | ||
| 1985 | $190.10M | — |
Revenue values are taken from West Pharmaceutical Services's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual revenue for West Pharmaceutical Services (WST) came in at $3.07B – grew 6.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, West Pharmaceutical Services revenue compounded at +7.4% per year, with the latest reading among the more recent periods of the dataset.
2025 marks the peak revenue at $3.07B, with the historical low of $190.10M recorded in 1985.
Within Healthcare, West Pharmaceutical Services (WST) ranks 9th among 8 peers we track. The peer median for revenue is $65.09B.
West Pharmaceutical Services Revenue by Year
West Pharmaceutical Services Revenue 2025: $3.07B
West Pharmaceutical Services revenue in 2025 was $3.07B, grew 6.3% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Revenue 2024: $2.89B
West Pharmaceutical Services revenue in 2024 was $2.89B, edged down 2.0% below 2023.
West Pharmaceutical Services Revenue 2023: $2.95B
West Pharmaceutical Services revenue in 2023 was $2.95B, edged up 2.3% from 2022.
West Pharmaceutical Services Revenue 2022: $2.89B
West Pharmaceutical Services revenue in 2022 was $2.89B, edged up 1.9% from 2021.
West Pharmaceutical Services Revenue 2021: $2.83B
West Pharmaceutical Services revenue in 2021 was $2.83B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Revenue
Companies in the same sector as West Pharmaceutical Services, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's revenue?
- Latest reported revenue for West Pharmaceutical Services (WST) is $3.22B (period ending March 31, 2026).
How has West Pharmaceutical Services revenue changed year-over-year?
- West Pharmaceutical Services (WST) revenue changed +6.3% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services revenue?
- West Pharmaceutical Services (WST) revenue compound annual growth rate is +7.4% over the most recent 5 years available.
When did West Pharmaceutical Services revenue hit its highest annual value?
- West Pharmaceutical Services revenue reached its highest annual value of $3.07B in 2025.
What was West Pharmaceutical Services revenue in 2024?
- West Pharmaceutical Services (WST) revenue in 2024 was $2.89B.
What was West Pharmaceutical Services revenue in 2025?
- West Pharmaceutical Services (WST) revenue in 2025 was $3.07B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.